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ABSTRACT 
Purpose: Ischemic preconditioning has been shown to have a positive effect on exercise 
performance. No studies to date have investigated whether there is a dose-response relationship 
evident in the IPC phenomenon. This study tested the hypothesis that ischemic preconditioning 
(IPC) would improve 2 kilometre (km) rowing time trial performance, and aimed to investigate 
whether a dose-response relationship existed. 
Methods:  
In a single-blind study, twelve healthy, injury-free subjects (8 males, 4 females; mean  SD 
age; 19  3 years, height 1.70  0.11 m; mass 69  12 kg), active to an elite level in Judo (Welsh 
National team) performed 3 rowing time trials. At the initial trial all participants performed the 
control study with no IPC intervention, for trial two 6 subjects were randomly allocated to 
either the 2 x 5’ IPC or 4x5’ IPC protocol. For the third trial a crossover was applied meaning 
that each participant completed the other IPC protocol. The IPC protocol was applied 45 
minutes prior to completing a 2km rowing ergometer time trial. 
Results: The time taken (mean  SD) to complete the 2km row was 487 (47), 486 (45) and 
481 (40) seconds for control, 2x5’ cycles and 4x5’ cycles of occlusion groups, respectively 
Repeated measures analysis of variance (ANOVA) revealed that overall 2km time trial 
performance did not differ statistically significantly between the three trials (F1.446, 15.910 = 
1.416, p = 0.265). There were statistically significant differences between the first 500m split 
times (F1.586, 17.444 = 14.799, p = 0.00); control trial (118  12s) and 2 x 5’ IPC trial (117  12s) 
were significantly faster than the 4 x 5’ IPC trial (122  11s, p = 0.029 and p = 0.000, 
respectively). There were some significant differences between the results of individual 500m 
splits within the 2km row; the first split in the control trial (118  12s) and in the 2 x 5’ IPC 
trial (117  12s) were both significantly faster than the 4 x 5’ IPC trial (122  11s, p = 0.029 
and p = 0.00, respectively). Split three in the control trial (125  11s) was significantly slower 
7 
 
than the 4 x 5’ IPC trial (121  9s, p = 0.048). Power (W) in split one was significantly higher 
in the 2x5’ IPC trial than the 4x5’ IPC trial (235  79W and 203  66W, p = .03).  
Calculation of effect sizes showed that all effects were classified as trivial (ES < 0.2) 
Conclusion: The data suggests that the IPC protocols utilized were not affective at improving 
overall 2km rowing time trial performance in elite trained Judoka.  
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CHAPTER ONE: INTRODUCTION  
Ergogenic preconditioning and priming strategies have increasingly studied in pursuit of 
marginal gains to improve sporting performance and IPC presents a potentially affective and 
practical strategy in this regard (23).  
Ischemic preconditioning (IPC) consists of short intermittent bouts of ischemia induced via 
arterial blood flow occlusion performed in order to reduce the negative effects of subsequent 
prolonged exposure to ischemia (typically of 3-4 x 5 minutes of occlusion interspersed with 5 
minutes of reperfusion) (18). IPC can be applied locally and remotely and is defined as a 
hermetic biphasic dose-response phenomenon whereby the protective affects to reduce infarct 
size on the myocardium are induced in subsequent prolonged exposure to ischemia (34,38). 
IPC has been shown to protect several organs from infarct in subsequent prolonged ischmia, 
including the myocardium (34), liver (36) and skeletal muscle (14). IPC has more recently been 
investigated for its potential benefits to sporting performance, with the first evidence shown by 
increased repeated force outputs in a forearm gripping test following IPC (27). 
A recent systematic review and meta-analysis of studies on IPC across all exercise types 
reported a small positive overall effect on performance (ES = 0.43; 90% confidence interval 
[CI], 0.28 to 0.51); with effect to aerobic (ES = 0.51; 90% CI, 0.35 to 0.67) and anaerobic (ES 
= 0.23; 90% CI, -0.12 to 0.58) exercise being larger than those observed for  power and sprint 
related activities (ES = 0.16; 90% CI, -0.20 to 0.52). (37). In another review of 21 studies (18), 
10 reported statistically significant benefits, with affects including; improved time trial 
performance (2,19,25), increased power output (7,8,37) and decreased perceived rate of 
exertion (2,9,26).  
The first study in the context of endurance exercise performance found an increased time to 
exhaustion in a cycling ramp test, which the authors postulated could be due to changes in 
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fatigue perception (8). Positive performance effects have subsequently been shown in several 
studies; these include a 34s improvement (95% confidence interval, 5–64 s; P = 0.027) in 
running time trial performance, attributed to a higher work rate allowed by an attenuated rise 
in blood lactate accumulation (2), 1000m rowing ergo time trial performance (from 186.5 ± 
3.6 to 185.7 ± 3.6 s; p < 0.05), (25), and increased (+3.7%, p < 0.05) power output at V02max 
(7). Studies investigating the mechanisms behind IPC have found enhanced vasodilation and 
increased oxygen delivery (3,20), attenuation of blood lactate accumulation (1,12,36), 
improvements in endothelial function (2) and ATP sparing effects (28). These effects are 
pertinent to improvements in exercise of an endurance nature thus research has predominantly 
focused on using IPC as a priming strategy for endurance based exercise.  
The optimal protocol (how to actually perform IPC) used in order to yield positive affects to 
exercise performance is still not clear (39). To date there are no studies directly investigating 
the effectiveness of IPC through comparison of different protocols. In the existing research 
doses of 3 x 5 minute or 4 x 5 minute periods of occlusion have been used and studies utilizing 
these doses have produced mixed results, with both beneficial and negligible effects to 
performance being shown (6,7,8,19,35). Recent systematic reviews of all the eligible studies 
suggest that there is no clear relationships between the use of either 3 or 4 sets of IPC and the 
size of the effect on subsequent exercise performance (18, 39).  
Studies using 4 x 5’ IPC prior to time trials of an endurance nature have observed statistically 
significant (p < .05) improvements in; 5km treadmill running time (-2.5%, using 220 mmHg 
occlusion) (2), 1km rowing sprint time (-0.4%, 40 mmHg above resting systolic blood pressure 
RSBP) (26) and time to failure in constant load cycling (+7.9%, 220 mmHg occlusion) (9). 4 
x 5’ IPC has also been observed to have no effect on: time to failure in graded maximal cycling 
(220 mmHg occlusion) (2) and time taken to cycle 100 kJ (20 mmHG above RSBP) (11). 
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Studies using 3 x 5’ IPC on endurance time trials have observed statistically significant (p < 
.05) improvements in: time to failure in maximal graded cycling (+3.6%, occlusion at 50 
mmHg above RSBP) (7), time to failure in constant load cycling ( +15.8%,  300 mmHg 
occlusion) (25). 3 x 5’ IPC has also been observed to have no effect on: 5km outdoor running 
time (50 mmHg above RSBP) (41), (2) and time to failure in graded maximal cycling (220 
mmHg occlusion) (6). The studies on endurance time trials have all used 2x5’ and 4x5’ IPC, 
with no studies using fewer cycles, however a study on RIPC (31) observed that 2 cycles of 
IPC in the legs, but not arms was enough to prevent endothelial ischemia-reperfusion 
dysfunction in the brachial artery, although no test was performed on to exercise performance, 
meaning conclusions cannot be drawn on whether performance would be effected from this 
lower IPC dose. RIPC is characterised by inducing an effect in organs that are non-local to the 
limbs where the occlusion is applied, for example effects on the myocardium after inducing 
ischemia on the legs. Research has also shown positive effects on power production in the squat 
jump (ES = 0.63) immediately following just 2 x 3 minutes unilateral leg occlusion at 220 
mmHg (3), indicating that fairly low-dose IPC can yield meaningful effects 
 
The aim of this study is to investigate whether improved endurance rowing performance can 
be achieved following IPC. The aforementioned studies show that 3x5’ IPC can be effective 
and this study aims to go further and see if as few as 2 x 5’ yields improvements; it is 
hypothesized that 2 x 5’ will improve time trial performance. The unique aim of this study is 
to directly compare 2 sets of 5’ occlusion-reperfusion with 4 x 5’ in order to investigate whether 
a dose-response exists. Due to the limited amount of existing research it is  not known whether 
4 x 5’ IPC will yield greater improvements in time trial performance than 2 x 5’IPC, thus this 
is a secondary aim of the study. 
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CHAPTER TWO: METHODS 
2.0 Participants 
In a single-blind, crossover study, twelve healthy, injury-free subjects (8 males, 4 females; 
mean  SD age; 19  3 years, height 1.70  0.11 m; mass 69  12 kg), active to an elite level 
in Judo (Welsh National team) were recruited to participate. Participants had a minimum 
training age of 8 years, with 2 years in a full time training environment; training time per week 
was 15 hours for all participants. The subjects were naïve about the effects of IPC, as assessed 
by a short questionnaire to assess their knowledge prior to testing. Participants and their legal 
guardians where appropriate were fully informed about the procedures involved and any 
associated risks and they were able to withdraw from the study at any time. Approval for the 
study's procedures was granted by St Mary's University Ethics Committee which conformed 
to the Declaration of Helsinki. 
2.1 Experimental Overview 
The subjects reported to the Welsh institute of Sport High Performance gym on four separate 
occasions. The initial visit was used to obtain anthropometric data on the participants and to 
gage their current level of knowledge about IPC. There was no need for a familiarization trial 
because all of the subjects had been tested on the 2km rowing time trial as part of their normal 
training program on at least three occasions prior to the study, The coefficient of variation (cv) 
from previous 2km rowing tests within Welsh Judo has always been measured at <10. The time 
trial itself required subjects to carry out a 2km row on a wind-braked rowing ergometer 
(Concept2, Morrisville, VT) as fast as possible following a standardized warm up. The 
concept2 rower has been found to be highly reliable at accurately recording distance rowed, 
average power and average stroke rate (30), thus it was deemed appropriate for the study. The 
first trial acted as the control for all subjects and no IPC procedure was performed, trials two 
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and three were the experimental trials and were preceded with either of the two IPC procedures 
in a randomized crossover fashion. The participants were randomly allocated to either of the 
protocols by pulling identification numbers out of a cup, with the first 6 subject drawn 
completing the 2x5’ IPC first and the remaining 6 completing 4x5’. This was followed by a 
crossover in the next experimental trial. Immediately following each 2km row participants 
indicated their rating of perceived exertion (RPE, 6–20; Borg scale). The trials were separated 
by 7 days in order to eliminate the carry-over of latent effects from the previous IPC protocol 
(28) and to allow time for full recovery. Following recommendations from previous research 
caffeine, alcohol, and exercise were restricted prior to the study for 24, 12 and 48 hours 
respectively (18). Each participant performed all of their trials using the same rowing 
ergometer at the same time of day (±1 h) and the temperature within the high performance gym 
was controlled at approximately 19° throughout all trials.  
2.2 Experimental Measures 
2.2.1 Ischemic Preconditioning 
In each of the experimental trials the 2km rowing time trial was preceded by ischemic 
preconditioning using an occlusion cuff (The Occlusion Cuff, Birmingham, UK). The 
occlusion cuff dimensions are 100cm long x 8 cm wide bladder with a 40cm extension for 
secure fastening. The cuff pressures were standardized to 220 mmHg, which has been shown 
to be an affective cuff pressure for inducing IPC effects in numerous studies (2,10,26). The 
lower limbs were alternately cuffed for 5 minutes of occlusion and 5 minutes of reperfusion 
and each IPC protocol was followed by a 25 minute break which preceded the standardised 
warm up. The warm up is then followed by a 2 minute break, meaning that the time trial started 
approximately 45 minutes after the IPC protocol was completed.  This 45 minute window of 
time between the IPC protocol and the exercise test has previously been shown to be 
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appropriate for yielding positive performance effects (19). The format of the trials, including 
the timing of each IPC protocol is illustrated clearly in figures 1-3. 
2.2.2 Rowing Time-Trial 
The warm up used was the standard protocol used in all British Judo performance centres, 
including Sport Wales. The prescribed warm up consisted of a 10-minute general dynamic 
warm up, then 1km rowing at a self-selected ‘easy’ pace, followed by 2 sets of 10 seconds of 
max effort separated by 50 seconds of ‘easy’ rowing. Following British Judo guidelines, the 
ergometer drag factor was set at 130 for males and 110 for females at all times. Following the 
time trial the participants completed a 20-minute cool down of low intensity cycling on a 
stationary bike. For the duration of the 2km row the all information on the ergometer display, 
other than distance remaining, was shielded from view of the participant in order to avoid the 
effect of pacing. Timekeeping devices of any sort were also not visible to the participant for 
the same reason. At the onset of the trial participants were instructed to “complete the 2km row 
as fast as you can” and no verbal encouragement was given once the 2km row was started. 
 
Figure 1. Control testing protocol. 
 
Figure 2. IPC testing protocol with 2 x 5’ occlusion. 
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Figure 3. IPC testing protocol with 4 x 5’ occlusion. 
Data was also recorded for on average for each 500m split and average for the 2km row on 
stroke rate per minute (SR) and power (W). The time it took to complete each 500m split was 
also measured. Rate of perceived exertion was measured by Borg Scale (4) immediately 
following each time trial. 
2.3 Statistical Analysis 
Power analysis was used to calculate the necessary number of participants; time trial 
performance was used as the main endpoint in one-way repeated measures ANOVA (G*Power 
3.1 Dusseldorf University, Germany), considering a mean difference of 2% between 
interventions (P value at 0.05 and power at 0.80), indicating that 5 subjects would be necessary. 
Data was analysed using the SPSS statistical software package (IBM SPSS Statistics 10.0 New 
York, USA);  data was checked for normality using Shapiro-Wilk normality test. Following 
this a one-way repeated measures ANOVA with three levels was used to examine if there were 
significant differences in the groups mean scores for 2km rowing for the experimental time 
trials using IPC, in comparison to the control trial. The significance level for assessing any 
differences in performance was set at 5%. Due to the importance of identifying marginal gains 
in the context of sport competition, effect sizes (Cohen’s d) were also applied to the data. Effect 
sizes of <0.2, <0.6, <1.2, <2.0 and >2 were considered to be trivial, small, moderate, large and 
very large, respectively (15). 
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CHAPTER THREE: RESULTS 
All participants completed all three of the time trials according to the schedule set at the outset 
of the study, the different scores between each trial are illustrated in figure 4. The mean scores 
of each measure in each 500m split across the three trials are shown in table 1. A one way 
repeated measures ANOVA with a Greenhouse-Geisser correction determined that mean 2km 
rowing time did not differ statistically significantly between the three time trials (F1.446, 15.910 = 
1.416, p = 0.265)There was a statistically significant difference between time taken to complete 
the first 500m split, between the three 2km rowing trials (F1.586, 17.444 = 14.799, p = 0.00).   The 
first split in the control trial (118  12s) and in the 2 x 5’ IPC trial (117  12s) were both 
significantly faster than the 4 x 5’ IPC trial (122  11s, p = 0.029 and p = 0.00, respectively). 
There was a statistically significant difference between time taken to complete the third 500m 
split, between the three 2km rowing trials (F1.899, 20.996 = 5.191, p = 0.016). Split three in the 
control trial (125  11s) was significantly slower than the 4 x 5’ IPC trial (121  9s, p = 
0.048).There was a statistically significant difference between SR of the first 500m split, 
between the three 2km rowing trials (F1.904, 20.393 = 3.911, p = 0.038), though post hoc analysis 
did not show any significant pairwise comparisons.  There was a statistically significant 
difference between SR of the third 500m split, between the three 2km rowing trials (F1.267, 13.993 
= 3.911, p = 0.018), though post hoc analysis did not show any significant pairwise 
comparisons.   
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Figure 4. Change in 2km rowing time trial performance by individual participants following ischemic 
preconditioning. Mean change (P >0.05) for the group displayed via dashed line. Table 1. Full results 
for 2km rowing time trial under each of the trial conditions; Control (No IPC), 2x5’ IPC and 4x5’ IPC. 
Table shows mean score for each group, Standard deviation and Effect sizes compared to control 
condition. Effect sizes <0.2, <0.6, <1.2, <2.0 and >2 were considered to be trivial, small, moderate, 
large and very large, respectively. 
There was a statistically significant difference between W of the first 500m split, between the 
three 2km rowing trials (F1.370, 15.073 = 9.801, p = 0.04), W in split one was significantly higher 
in the 2x5’ IPC trial than the 4x5’ IPC trial (235  79W and 203  66W, p = .03). Results are 
shown in Table 1. 
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Measure Control IPC 2x5’ IPC 4x5’ df F Sig. 
RPE 8.8  1.11 9.5  .52 9.4  .79 1.69 1.990 .169 
2km time 487 13 486  13 481  12 1.446 1.416 .265 
Split 1 time 118  12 117  12 122  11 1.586 14.799 .000* 
Split 2 time 123  12 124  12 124  10 1.975 1.226 .313 
Split 3 time 125  11 124  11 121  9 1.899 5.191 .016* 
Split 4 time 122  12 121  10 120  10 1.151 1.410 .263 
Split 1 stroke rate 37  5.4 38  5.4 36  4.3 1.904 3.911 .038* 
Split 2 stroke rate 35  4.4 36  4.8 36  5.0 1.590 1.431 .262 
Split 3 stroke rate 34  4.4 35  4.7 37  5.5 1.267 6.544 .018* 
Split 4 stroke rate 35  5.3 37  5.7 36  5.3 1.454 2.596 .117 
Split 1 power (W) 226  77 235  79 203  66 1.370 9.801 .004* 
Split 2 power (W) 199  59 194  63 191  50 1.922 1.462 .252 
Split 3 power (W) 190  53 191  58 205  45 1.677 3.476 .240 
Split 4 power (W) 205  59 208  58 210  55 1.256 .927 .475 
 
Table 1. Full results with ANOVA for 2km rowing time trial under each of the trial conditions; 
Control (No IPC), 2x5’ IPC and 4x5’ IPC. Table shows mean score for each group, Standard 
deviation and results of ANOVA between the three trial conditions. Post hoc tests using the 
Bonferroni correction applied to identify where significant differences occurred. Alpha level for 
significance was set at p<.05. 
 
Neither IPC protocol had a statistically significant effect on overall 2km rowing time-trial 
performance, though there were some significant differences observed between the individual 
500m splits. All of the effect sizes were calculated by Cohen’s d are classified as trivial (ES < 
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0.2), apart from RPE where a small effect was observed between control and IPC trials (ES < 
0.4) as shown in Table 2. 
 
Control 
Mean         SD 
 
      2 x 5’ cycles 
      Mean        SD          ES    
4 x 5’ cycles 
Mean         SD           ES    
RPE 8.8 1.11 9.5       .52       .37 9.4 .79            .29 
Time 
2km time 487.30  46.81   484.34  42.61   .03    482.69  42.75    .06  
Split 1 time 117.93  12.49 115.89  12.07   .08  115.14  11.24    .13 
Split 2 time 122.87  11.57 123.17  12.10   .00 123.15  11.45    .00 
Split 3 time 124.55  11.37 124.05  10.06   .05   124.37  11.12    .05 
Split 4 time 121.73  11.67 121.40   9.27   .05 120.11  9.68   .09 
Stroke rate 
2km average 34.98  4.59 36.42  4.62    .01  35.83  5.02    .01 
Split 1  36.92  5.43 38.00  4.22    .01 37.92  5.25    .01 
Split 2  34.67  4.36 36.17  4.20    .01 35.50  4.87   .00 
Split 3  33.58  4.36 35.75  4.86    .02 35.17  4.90   .02 
Split 4  35.42  5.33 36.83  5.77    .18 36.33  5.33   .09 
Power (W) 
2km average  206.55  60.16 206.46  59.73  .00 208.88  61.39   .02 
Split 1  226.17  76.60 240.58  86.46  .09 242.67  76.63   .10 
Split 2  198.58  59.11 199.25  68.32  .00 197.42  60.71   .02 
Split 3  189.86  52.87 190.50  50.47  .00 191.08  57.39   .00 
Split 4  204.75  58.71 202.42  47.73  .03 210.08  55.41   .04 
 
 
Table 2. Full results with effect sizes for 2km rowing time trial under each of the trial conditions; 
Control (No IPC), 2x5’ IPC and 4x5’ IPC. Table shows mean score for each group, Standard 
deviation and effect size between the three trial conditions.  
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CHAPTER FOUR: DISCUSSION 
The primary focus of the study was to examine whether ischemic preconditioning had an effect 
on 2km rowing time trial performance. A secondary aim was to investigate whether there was 
a dose-response relationship between the number of cycles of occlusion-reperfusion performed 
and the subsequent time trial performance. The 2km rowing test is suitable as it is the standard 
aerobic capacity test used by British Judo and this study’s sample was made up of elite Judoka 
who are all familiar with the test. A 2km row is characterized by the reliance mainly on aerobic 
metabolism, with rowers typically working at a rate greater than 90% of their maximal aerobic 
capacity throughout a period of approximately six to nine minutes of activity (21). In 
consideration of the aforementioned existing literature, and based on the duration of a 2km row 
and the intensity of sustained effort the hypothesis of this study was that IPC would have a 
positive effect on time trial performance. The study aimed to establish whether there was a 
dose-response relationship between the number of cycles of occlusion-reperfusion applied, and 
the size of any observed effects. 
This study does not any significantly significant difference between the overall time trial 
performance under the three trial consitions, with neither IPC protocols having any affect on 
performance, either positive or negative.  The individual performances for each participant 
were also variable, as shown in table 1. It is however worth noting that within the context of 
elite performance coaches and athletes still might consider that even tiny differences would 
represent some degree of ‘competitive significance’, thus effects that are classified as trivial in 
a statistical analysis may still be deemed worthy of further examination within the context of 
elite sport. Although in this same regard the small detrimental effects on some participants 
should be considered.  
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The improvements observed in power, time and SR indicate that the subjects generally 
employed a better pacing strategy for the 4x5’ IPC trial, as shown by improved performance 
in split three, compared to a reduction in pace, power and SR in split one. The lack of significant 
change in the overall 2km time trial performance indicates that any changes were likely a result 
of changes in pacing, rather than genuinely improved performance.  
The randomised crossover design of the study aimed to reduce the potential for any influence 
deriving from test order, however it would be more accurate to treat the control study as part 
of the crossover too, in order to avoid learning or pacing effects that may have benefited the 
subsequent IPC trials. The limited pool of elite Judoka with which this study had to recruit 
from resulted in a fairly small group of 12 which may also contribute to the lack of significance. 
Thus it is worth examining the potential reasons behind the lack of statistical significance and 
exploring whether adjustments to the methodology might yield more meaningful results.  
Initially it is worth questioning the accuracy of the time trial results as a true representation of 
maximal performance. The 2km rowing time trial is an extremely demanding test, both 
physically and psychologically. The participants would normally complete this test once every 
2-3 months as part of their normal training in regime, whereas they were required to complete 
it 3 weeks running for the purpose of this study. Although anecdotal, it was evident that the 
participants did not always seem fully motivated at the onset of each trial. To avoid this prior 
to each trial, participants were always asked if they were ready to give their best effort, and 
also asked to record a RPE following each trial. Although subjects always reported that they 
gave their best effort and recorded RPE’s of >8 (Table 1), these self-reported measures of 
motivation and effort are arguably open to subject bias. Furthermore, actual fatigue from 
residual training effects is very hard to control in a study on this type of group and despite all 
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participants avoiding training for 48 hours per-test, the chronic fatigue experienced from elite 
level training cannot be underestimated. 
The cohort of participants are highly trained athletes and are well accustomed to this particular 
rowing test. Previous research has indicated that trained individuals are more resistant to the 
effects of ischemia than non-trained (22,31), therefore the scope for improvement following 
IPC might be reduced. However, research on IPC has shown improvements in performance in 
both trained and non-trained groups, and have indicated that the effect may actually be higher 
in trained individuals (19, 25,13). Indeed, the 4x5’ IPC protocol has been shown to provide 
positive effects in “well-trained” individuals with a V02max averaging 56.8ml/kg/min (8). In 
consideration of the existing research it is unlikely that the effects of IPC were inhibited by the 
trained-state of the participants. It could also be the case that the athletes are so familiar with 
the ‘feeling’ of their usual 2km rowing pace that they stayed very close to this for all trials. 
Several studies have shown that IPC can improve performance in endurance tests measuring 
aerobic capacity (2,6,7,25). One particularly pertinent study (2), found improved 5km running 
time trial performance of 34 seconds following IPC compared to a control condition, despite 
no significant changes to heart rate, V02max or blood lactate accumulation in the trial following 
IPC. Following IPC a phenomenon of reactive hyperemia occurs, whereby there is a 
substantially increased level of blood flow to the muscles (42). This effect has been shown as 
one of the contributing factors that facilitates protection from subsequent prolonged ischemia 
(32), and may explain potentially increased exercise performance (8). Though research has also 
found reduced time to fatigue during an incremental biking test, despite no change in cardiac 
output, stroke volume or oxygen uptake; indicating that blood flow may not be a contributing 
factor (7). In this study anecdotally, almost all of the participants reported that their legs felt 
“slow”, “sore” and “heavy” during the experimental trials following IPC. Subjective pain from 
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IPC has been shown as higher in the legs (41) and this may have contributed to a sense of 
fatigue that impacted on participants’ performances, thus reducing the potential for 
significantly improved performance. If remote occlusion was performed, to the arms for 
example, then perceived pain would be lower which may have reduced subsequent reported 
‘soreness’ at the onset of the time trial. This approach may have led to improvements due to 
the yielding of possible RIPC effects observed in research (1), combined with a potential 
reduction in the negative effects of perceived muscle soreness. 
Due to the relatively young age and small size of the participants (19  3 yr, height 1.70  0.11 
m; mass 69  12 kg) it could be that the cuff inflation pressure used (220 mmHg) was too high. 
Research has shown that a significant increase in blood lactate levels was noted once cuff 
inflation pressure reached 180 mmHg in the lower limb, and that 5 minutes reperfusion is 
enough to see levels return to baseline (38). These findings show that ischemia can be induced 
at lower pressures than we used, though the researchers did not study whether these lower 
pressures would still induce any exercise improvements. Cuff pressures for IPC have also been 
set by working from RSBP; with pressures set at increments ranging from 15 mmHg (19) and 
20 mmHg; (11) right up to 50 mmHg (7) above RSBP. This method has been used as the 
preferred method in studies using children as subjects (5). Considering the age and size of the 
subjects in this study it is possible that the buildup of metabolites within the muscle was high 
and that levels had not returned to baseline by the time the time trial started, though no lactate 
readings were taken so this is mere speculation. Additionally, some studies have actually 
reported decreased levels of phosphocreatine (PCr), adenosine triphosphate (ATP), and 
reduced buffer capacity shortly following IPC, (36,40) highlighting the importance of 
sufficient recovery to allow levels to return to baseline prior to exercise. However, in this study 
45 minutes was allocated and this time has generally been shown to be sufficient to yield 
performance gains (19).  
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Conversely to the above, it may actually be that there were no significant effects because true 
ischemia was never obtained during IPC. Indeed, some studies have shown that arterial blood 
flow in some cases could not be blocked even at pressures as high as 250 mm Hg (17,29). A 
major limitation to our study was that no scientific equipment was used to measure and ensure 
that ischemia was actually achieved. Based on meta-analysis of existing research it is 
recommended that studies use near-infrared spectroscopy or Doppler flow measurement to 
establish whether the arterial blood flow has been fully blocked (39). We did not perform any 
kind of measurement to check whether arterial blood flow was blocked, thus, although it is 
likely, we cannot be truly certain that IPC was performed affectively.  
In conclusion, IPC performed on the legs using standardized cuff pressures off 220 mmHg for 
doses of both 2 x 5’ and 4 x 5’ occlusion-reperfusion did not have an effect on overall 2km 
rowing ergometer time-trial performance. There were some significant changes to the time 
taken, power exerted and stroke rate maintained in the individual 500m splits, though it is 
possible that this was due to improved pacing strategy, rather than the effects of IPC. The study 
requires a broader and more accurate range of scientific measures to identify the reasons behind 
the findings, in order to conclude whether effects, or lack of effects arose from methodological 
error, or through true ineffectiveness of IPC in this particular context. 
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Section A: The Research Project  
 
 
Title of project 
 
 
IPC and 2km rowing time trial performance: two versus four cycles of occlusion-reperfusion. 
 
 
Purpose and value of study 
This study compares the effects of two different ischemic preconditioning (IPC) protocols which will 
be undertaken prior to completing respective 2km rowing time trials. The study aims to provide 
further data on the effect of IPC on time trial performance and to provide further direction on 
whether there is a does-response relationship between IPC and time trial performance. 
 
 
31 
 
Invitation to participate 
You are invited to be a participant in this study. If you accept this invitation you will be asked to 
come in to the Sport Wales sport science lab for three testing days which are 9th, 16th and 23rd 
January 2017. 
 
 
Who is organising the research 
The research is being organised by Tom Reed as part of a Masters Degree dissertation through St 
Mary's University. Supervisors are Dr Stephen Patterson and Jess Hill. 
 
 
What will happen to the results of the study 
Your results will be anonymised and then used in the analysis of data to be presented in the 
dissertation. Results will be presented as a group, meaning that no individual scores are shown and 
that it will not be possible to recognise the performance of specific participants. 
 
 
Source of funding for the research 
There are no sponsors or other sources of funding for this research. Any associated costs will be 
borne by the researcher, Tom Reed. 
 
 
Contact for further information 
I, the researcher, can be contacted by email or telephone using the details listed below. Please feel 
free to approach me for any further information that you require. 
Email: reedtom86@gmail.com, 125281@live.smuc.ac.uk 
Phone: 07853386580 
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Section B: Your Participation in the Research Project 
 
 
Why you have been invited to take part 
All the participants for the study will be taken from the athlete's on the Welsh Judo Talent Cymru 
development squad. 
 
 
Whether you can refuse to take part 
Your participation in this study is voluntary and you may refuse to take part. However, it is expected 
that once you agree to take part in the study that you are committed to attending the three testing 
days. 
 
 
Whether you can withdraw from the project at any time, and how 
You are able to withdraw from the study at any time, by completing the section on the Consent 
Form entitled 'I wish to withdraw from this study' and returning it to the researcher in person or by 
email on the given contact details. 
 
 
What will happen if you agree to take part (brief description of procedures/tests) 
This study looks at your performance in a 2km rowing time trial on a concept 2 rowing machine. We 
are comparing the effects of two different IPC protocols which you will undergo before completing 
the 2km rowing tests. IPC stands for Ischemic Pre-Conditioning and is a technique that involves using 
a pressure cuff that is wrapped around a limb, in this case one leg at a time, in order to restrict the 
blood flow to the muscles. 
 
 
You will be asked to come in to the Sport Wales sports science lab on three occasions to do the 2km 
row, which will separated by seven days. Prior to each row, just before the warm up you will 
33 
 
undergo one of the IPC protocols using an occlusion cuff. In the first testing day you will perform the 
time trial without IPC in order to obtain a baseline score. 
 
 
The occlusion cuff IPC procedure will be administered by the researcher, Tom Reed, under the 
supervision of the Welsh Judo strength and conditioning coach. The 2km rowing time trial warm up 
and testing format will be the same as the normal format you follow in your regular fitness 
monitoring program. The cuff will be used to temporarily restrict your blood flow using pressures no 
greater than what you would have experienced during a normal blood pressure measurement. The 
cuff will be applied to one leg for five minutes, then the other, for either 2 or 4 cycles per leg. 
 
 
Whether there are any risks involved (e.g. side effects) and if so, what will be done to ensure 
 your wellbeing/safety 
There are no known risks involved with the testing protocol. You may experience moderate 
discomfort due to the restriction of blood flow. Experienced strength and conditioning professionals 
will be present at all times to mitigate the possibility of unforeseen risks. 
 
 
Agreement to participate in this research should not compromise your legal rights if something goes 
wrong 
?? 
 
 
Whether there are any special precautions you must take before, during or after taking part in  the 
study 
You should refrain from caffeine, alcohol, and exercise prior to the study for 24, 12 and 48 hours 
respectively. 
 
 
What will happen to any information/data/samples that are collected from you 
All information received from you and all testing data will be kept confidential, only the researcher 
and strength and conditioning coach will have access to data relating to your testing. Data will be 
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stored on the secure server on the St Mary’s University server, and any paper documents will be 
kept in a locked cupboard at all time that only the researcher can access. 
 
 
Whether there are any benefits from taking part 
The 2km time trial will count as your winter fitness monitoring test for your normal Talent Cymru 
testing, and an analysis of your performance can be provided at your request. 
 
 
How much time you will need to give up to take part in the project 
you will be asked to come in to the Sport Wales sport science lab for three testing days which are 
9th, 16th and 23rd January 2017. Therefore by agreeing to take part in this study you should be 
available on those days. Each testing day will take approximately 90 minutes in total. 
 
 
How your participation in the project will be kept confidential 
As mentioned previously, your results will be anonymised and no record of your name or 
participation will appear on any of the study documents. You will be assigned a participant number 
and will be referred to using this on all of the documentation. The results will be presented in the 
final write up as a group. Only the researcher and the coaches at Welsh Judo will know about your 
participation in the study. 
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Name of Participant: _________________________________________ 
 
Title of the project:  _ 
IPC and 2km rowing time trial performance: two versus four cycles of occlusion-reperfusion._ 
 
Main investigator and contact details:   _Tom Reed, reedtom86@gmail.com, 125281@live.smuc.ac.uk, 
07853386580_______________________________ 
 
Members of the research team: Dr Stephen Patterson, Jess Hill 
 
 
1. I agree to take part in the above research.  I have read the Participant Information Sheet which  is 
attached to this form.  I understand what my role will be in this research, and all my questions  have been 
answered to my satisfaction. 
2. I understand that I am free to withdraw from the research at any time, for any reason and 
without prejudice. 
3. I have been informed that the confidentiality of the information I provide will be safeguarded. 
4. I am free to ask any questions at any time before and during the study. 
5. I have been provided with a copy of this form and the Participant Information Sheet. 
 
Data Protection:  I agree to the University processing personal data which I have supplied.  I agree to the 
processing of such data for any purposes connected with the Research Project as outlined to me. 
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Name of participant (print)……………………………………………………………………………..     
 
 
Signed………………..…………………                                    Date…………………………......... 
 
 
---------------------------------------------------------------------------------------------------------------------------- 
 
If you wish to withdraw from the research, please complete the form below and return to the main 
investigator named above. 
 
Title of Project: ______________________________________________________________ 
 
 
I WISH TO WITHDRAW FROM THIS STUDY 
 
 
Name: _________________________________________ 
 
 
Signed: __________________________________        Date: _____________________ 
 
 
 
 
